Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > December 2016

« Previous month Next month »

CytoBioscience buys formulation safety tech company in Alabama for millions

22-Dec-2016 - Cytobioscience Inc, has acquired Soluble Therapeutics Inc to expand its high throughput formulation screening capabilities.

Data integrity concerns: EMA reviews drugs tested by Micro Therapeutic Research

22-Dec-2016 - The EMA has started reviewing drugs tested by Micro Therapeutic Research Labs after an inspection by Dutch and Austrian regulators identified potential data integrity problems.

Lonza contracted to make API for Aurinia's lupus nephritis candidate

21-Dec-2016 - Lonza has been contracted to the API for a candidate lupus nephritis treatment by Canadian developer Aurinia Pharmaceuticals Inc. 

AstraZeneca opens UK Zoladex plant

21-Dec-2016 - AstraZeneca has opened a £120m ($148m) cancer treatment manufacturing site in Macclesfield in the UK.

Wacker adding cysteine capacity through Spanish acquisition

21-Dec-2016 - Wacker says it is buying a large-scale fermentation facility in Spain to support growing demand for the amino acid cysteine.

Laboratorio Angulema warned by Spanish regulators about Leganes plant

20-Dec-2016 - Spanish regulators have found problems at a facility operated by immunotherapy producer Laboratorio Angulema.

US FDA has concerns about Granules - Ajinomoto OmniChem's Vizag API plant

20-Dec-2016 - US FDA inspectors have raised questions about an API manufacturing facility in India that is operated by Granules India and Ajinomoto OmniChem.

DuPont gets Gates grant for protein drug production platform

20-Dec-2016 - DuPont has joined a Gates Foundation backed effort to develop low cost production methods for therapeutic proteins.

News in brief

Claris to sell injectable drug business and facilities to Baxter

19-Dec-2016 - Baxter International has agreed to pay Claris Lifesciences $625m (€598m) for three manufacturing facilities and a portfolio of 11 approved injectable drugs.

Strides Shasun buys Perrigo’s US FDA-approved API plant in India

19-Dec-2016 - Bangalore’s Strides Shasun Ltd. has acquired Perrigo API India ltd and its active pharmaceutical manufacturing portfolio for generics for INR1bn ($14.7m).

apceth Biopharma joins Lonza as bluebird bio cell therapy contractor

15-Dec-2016 - bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.

Cipla to make drugs in Iran in deal with Ahran Tejarat

15-Dec-2016 - Cipla Ltd has formed a joint venture with Ahran Tejarat Company to manufacture and sell drugs in Iran.

Lonza to buy Capsugel for $5.5bn, no site divestitures planned

15-Dec-2016 - Lonza has agreed to buy US capsule manufacturer Capsugel for $5.5bn (€5.2bn) in cash in an acquisition the Swiss firm says will expand its drug delivery business and enable savings...


Sugar lumps? Excipient impurities may be risk to patients says researcher

14-Dec-2016 - Newly identified impurities in sugar excipients pose a risk to patients and could explain why some drugs fail safety tests according to scientists from the Netherlands.

US FDA slams delivery patch firm Pocono Coated Products over sub-potent meds

14-Dec-2016 - The US FDA has criticized Pocono Coated Products' (PCP) efforts to bring its transdermal patch plant in Cherryville, North Carolina into compliance with cGMP standards.


Syngene's Bengaluru site damaged by fire

13-Dec-2016 - A fire has damaged a facility operated by Indian contractor, Syngene International. 

News in brief

CMO Evonik acquires silica business for $630m

13-Dec-2016 - Evonik Industries AG has acquired the silica business from the US company J.M. Huber, expanding the company’s presence in North America and Asia.

Skanska gets $45m contract to refit US GSK R&D hub

13-Dec-2016 - GSK has hired Skanska AB to renovate its laboratory and office in Upper Providence, Pennsylvania, US in a $45m (€42m) project.

News in brief

US FDA OKs Akorn plant after re-inspection

13-Dec-2016 - The US FDA has given Akorn Pharmaceuticals' facility in Decatur, Illinois a clean bill of health after a re-inspection last week. 

Saneca gets Gov grant to invest in API plant

13-Dec-2016 - The Slovakian Government has granted Saneca Pharma €1.5m ($1.6m) to invest in ‘green’ API manufacturing and anti-abuse technologies for its opiate-based drugs.  

A Roche of la Grippe: India’s Natco and Alvogen launch Tamiflu generic in US

13-Dec-2016 - Natco Pharma and partner Alvogen have launched the “first generic equivalent” of Roche’s Tamiflu (oseltamivir phosphate) in the US.

Lonza confirms interest in Capsugel takeover

12-Dec-2016 - Lonza has confirmed it is interested in buying Capsugel. 

Growth in biologics and vaccines leading injectables business, Aptar Pharma

12-Dec-2016 - Aptar Pharma is nearing completion of its US-based manufacturing site, as it continues to expand globally to keep pace with growth in the injectable drug delivery industry.

News in brief

Alkem issued with Form 483 by US FDA

12-Dec-2016 - The US FDA has issued Indian API firm Alkem Laboratories Ltd. with a Form 483 after an inspection at is site in Ankleshwar, Gujarat.

Catalent joins industry group supply chain initiative

12-Dec-2016 - Catalent has become the first CDMO to join the PSCI – a voluntary industry initiative focused on the social, environmental and economic impact of the supply chain.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...